跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREGABALIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PREGABALIN
Authorized
STANDARD
PREGABALIN
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8802ec9809c9ceff
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
8802ec9809c9ceff
Drug Approval Canada Name
PREGABALIN
Product Name
PREGABALIN
Status
Cancelled Post Market
Status Date
2022-01-03
Original Market Date
2018-06-06
Din
02476312
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N02BF02 PREGABALIN
Atc Name
n 02 bf 02
Aig Number
0151121002
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
PREGABALIN
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8802ec9809c9ceff
Type
Standard
Back to Health Canada Approvals